Cordlife Group Limited

Research Cordlife Group Limited (P8A.SI) on Bullrun: market cap SGD 31.01M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerP8A.SI
ExchangeSGX
CountrySingapore
SectorHealthcare
IndustryDiagnostics & Research
CurrencySGD
Market capSGD 31.01M
Financial periodQ2 2026
RevenueSGD 8.30M
Net income-SGD 936.00K
Free cash flow-SGD 320.00K
Gross margin58.5%

Valuation Snapshot

latest market cap is SGD 31.01M.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	SGD 31.01M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SGD.

About Cordlife Group Limited

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings;

Related stock research

Singapore stocks Singapore Healthcare stocks A-Z stock index

Other Healthcare stocks

HC Surgical Specialists Limited (1B1.SI) Clearbridge Health Limited (1H3.SI) AsiaMedic Limited (505.SI) Aoxin Q & M Dental Group Limited (1D4.SI) Hyphens Pharma International Limited (1J5.SI) ISEC Healthcare Ltd. (40T.SI) iX Biopharma Ltd. (42C.SI) Vicplas International Ltd (569.SI) AJJ Medtech Holdings Limited (584.SI) Meta Health Limited (5DX.SI) Asia Vets Holdings Ltd. (5RE.SI) OUE Healthcare Limited (5WA.SI)

Frequently asked questions

What is Cordlife Group Limited's market cap?

Cordlife Group Limited's market capitalization is SGD 31.01M.